Evidence map›Paper›PMID 31028216›Full record

ArticleIn vivo (Athens, Greece)

The Choice of Drainage Device in Complicated Glaucomas: Comparing Ahmed and Baerveldt Implants.

Marilita M Moschos, Eirini Nitoda, Nikolaos Gouliopoulos, Christos Damaskos, Konstantinos Laios, Eleni Bagkli, Nikolaos Garmpis, George Kitsos

Erratum issuedOpen access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Marilita M MoschosFirst Department of Ophthalmology, University of Athens Medical School, G. Genimmatas General Hospital Athens, Athens, Greece moschosmarilita@yahoo.fr.
Eirini NitodaFirst Department of Ophthalmology, University of Athens Medical School, G. Genimmatas General Hospital Athens, Athens, Greece.
Nikolaos GouliopoulosFirst Department of Ophthalmology, University of Athens Medical School, G. Genimmatas General Hospital Athens, Athens, Greece.
Christos DamaskosSecond Department of Propedeutic Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
Konstantinos LaiosFirst Department of Ophthalmology, University of Athens Medical School, G. Genimmatas General Hospital Athens, Athens, Greece.
Eleni BagkliDepartment of Ophthalmology, Medical School of University of Ioannina, Ioannina, Greece.
Nikolaos GarmpisSecond Department of Propedeutic Surgery, Laiko General Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece.
George KitsosDepartment of Ophthalmology, Medical School of University of Ioannina, Ioannina, Greece.
National and Kapodistrian University of Athens · GRUniversity of Ioannina · GRLaiko General Hospital of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimGlaucoma is a chronic and progressive optic neuropathy which leads to deterioration of visual function. It is estimated to be the second leading cause of severe vision loss and blindness worldwide. Failure of anti-glaucoma medication to sufficiently reduce intraocular pressure (IOP) and poor compliance with medication are indications for glaucoma surgery, for example using glaucoma drainage devices. Our aim was to compare the surgical outcomes following the implantation of Ahmed FP7 and Baerveldt 350 drainage devices. PATIENTS AND

methodsFive hundred and fifty-two patients with primary or secondary glaucoma were enrolled in the study. All patients had a history of failed trabeculectomy or other intraocular surgery, and IOP ≥18 mm Hg. The implantation of Ahmed (266 patients) or Baerveldt (286 patients) devices was randomly performed in the patients, who were subsequently examined for a period of 5 years. Follow-up visits were scheduled 1 day; 1 week; 1, 3 and 6 months; and 1, 1.5, 2, 3, 4 and 5 years postoperatively.

resultsSignificant reduction of IOP was achieved in both groups. Ahmed valve (28.3±9.3, 13.4±6.9, 14.2±6 and 12.7±4.5 mmHg at baseline, 1, 3, and 5 years postoperatively, respectively) resulted in significantly greater IOP reduction compared to Baerveldt implant (29.6±10.1, 15.4±5.5, 14.5±5.5 and 14.7±4.4 mmHg at baseline, 1, 3, and 5 years postoperatively, respectively). A significantly lower number of medications was required in the Ahmed group in comparison to the Baerveldt one (Ahmed group: 1.5±1.4, 1.4±1.5 and 1.8±1.5; Baerveldt group: 1.9±1.3, 1.9±1.3 and 2.2±1.4, respectively). The incidence of treatment failure and the rate of glaucoma reoperation were significantly higher in the Baerveldt group (40%) compared to the Ahmed group (17%).

conclusionAhmed drainage implantation seemed to outclass that using the Baerveldt device in our study, in terms of efficacy and success rate.

Indexed as

Clinical Decision-MakingCross-Sectional StudiesDisease ManagementDrainageFemaleGlaucomaGlaucoma Drainage ImplantsHumansIntraocular PressureKaplan-Meier EstimateMaleMiddle AgedPostoperative ComplicationsTreatment FailureTreatment OutcomeAhmedBaerveldtdrainageglaucomaimplantvalve

Identifiers

PMID31028216
PMCPMC6559893
OpenAlexW2941465147

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.